The expression of Fas ligand by macrophages and its upregulation by human immunodeficiency virus

Journal of Clinical Investigation

Volumn 101, Issue 11, 1998, Pages 2394-2405

  Dockrell, David H ^a   Badley, Andrew D ^a,e   Villacian, Jorge S ^a   Heppelmann, Carrie J ^a   Algeciras, Alicia ^a   Ziesmer, Steven ^a   Yagita, Hideo ^c   Lynch, David H ^d   Roche, Patrick C ^a   Leibson, Paul J ^b   Paya, Carlos V ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c JUNTENDO UNIVERSITY   (Japan)

^d AMGEN INC   (United States)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

HIV induced upregulation of FasL in macrophages

Indexed keywords

FAS LIGAND;

ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPATHOGENESIS; LYMPHOCYTE DEPLETION; LYMPHOID TISSUE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 0032103109     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1171     Document Type: Article

References (56)

1. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the Tumor Necrosis Factor family. Cell. 75:1169-1178.
2. Trauth, B.C., C. Klas, A.M.J. Peters, S. Matzku, P. Moller, W. Falk, K.-M. Debatin, and P.H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:301-305.
3. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873-879.
4. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBOJ. 14:1129-1135.
5. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Imnumol. 154:3806-3813.
6. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P.M. Krammer. 1995. Autocrine T-cell suicide-mediated by APO-1/(Fas/CD95). Nature. 373: 438-441.
7. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:441-444.
8. Ju, S.-T., D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:444-448.
9. Singer, G.G., and A.K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:365-371.
10. Russell, J.H., B. Rush, C. Weaver, and R. Wang. 1993. Mature T-cells of autoimmune lpr/lpr mice have a defect in antigen stimulated suicide. Proc. Natl. Acad. Sci. USA. 90:4409-4413.
11. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235-1238.
12. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science. 265:528-530.
13. Katsikis, P.D., E.S. Wunderlich, C.A. Smith, L.A. Herzenberg, and L.A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:2029-2036.
14. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185:55-64.
15. + T lymphocytopenia. J. Clin. Invest. 97:672-680.
16. Galle, P.R.,. W.J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P.H. Krammer, and L. Runkel. 1995. Involvement of the CD95 (Apo-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223-1230.
17. Muller, M., S. Strand, H. Hug, E-M. Heinemann, H. Walczak, W.J. Hofmann, W. Stremmel, P.H. Krammer, and P.R. Galle. 1997. Drug induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99:403-413.
18. Fisher, G.H., F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middelton, A.Y. Lin, W. Strober, M.J. Lenardo, and J.M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81:935-946.
19. Strasser, A. 1995. Death of a T cell. Nature. 373:385-386.
20. Vignaux, F., E. Vivier, B. Malissen, V. Depraetere, S. Nagata, and P. Golstein. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181: 781-786.
21. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: 1pr and gld mutations. Immunol. Today. 16:39-43.
22. Boehme, S.A., and M.J. Lenardo. 1993. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 23: 1552-1560.
23. Munn, D.H., J. Pressey, A. Beall, R. Hudes, and M.R. Alderson. 1996. Selective activation-induced apoptosis of peripheral T cells imposed by macrophages. J. Immunol. 156:523-532.
24. Wu, M.X., J.F. Daley, R.A. Rasmussen, and S.F. Schlossman. 1995. Monocytes are required to prime peripheral blood T cells to undergo apoptosis. Proc. Natl. Acad. Sci. USA. 92:1525-1529.
25. + antigen-specific T cells to undergo apoptosis by HIV-infected monocytes; a two step process involving the gp120 molecule. J. Clin. Invest. 99:257-266.
26. Macatonia, E., S. Patterson, and S.C. Knight. 1991. Primary proliferation and cylotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunology. 74:399-406.
27. + CTLs from naive precursors. J. Immunol. 153: 996-1003.
28. + T cell lines from naive precursors. Eur. J. Immunol. 25:1206-1211.
29. + precursors. J. Immunol. 158:2134-2142.
30. Badley, A.D., J.A. McElhinny, P.J. Leibson, D.H. Lynch, M.R. Alderson, and C.V. Paya. 1996. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:199-206.
31. + dendritic cells. Proc. Natl. Acad. Sci. USA. 93:2588-2592.
32. Dulbecco, R. 1988. Endpoint method-measurement of the infectious titer of a viral sample. In Virology: The Nature of Viruses, 2nd ed. J.P. Lippincott, Philadelphia. 22-25.
33. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and. H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777-1783.
34. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and H. Nagata. 1994. Human Fas ligand: gene structure, chormosomal location and species specificity. Int. Immunol. 6:1567-1574.
35. Panoskaltsis-Mortari, A., and R.P. Bucy. 1995. In situ hybridization with digoxigenin labeled RNA probes: facts and artifacts. Biotechniques. 18:300-307.
36. Falini, B., L. Flenghi, S. Pileri, M. Gambacorta, B. Bigerna, H. Durkop, F. Eitelbach, J. Thiele, R. Pacini, A. Cavaliere, et al. 1993. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule. Am. J. Pathol. 142:1359-1372.
37. Kahn, H.J., A. Marks, H. Thom, and R. Baumal. 1983. Role of antibody to S100 protein in diagnostic pathology. Am. Soc. Clin. Pathol. 79:341-347.
38. Nakajima, M., A. Nakajima, N. Kayagaki, M. Honda, H. Yagita, and K. Okumura. 1997. Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury. Clin. Immunol. Immunopathol. 83:223-229.
39. Kaplan, G., and G. Gaudernack. 1982. In vitro differentiation of human monocytes. J. Exp. Med. 156:1101-1114.
40. O'Doherty, U., R.M. Steinman, M. Peng, P.U. Cameron, S. Gezelter, I. Kopeloff, W.J. Swiggard, M. Pope, and N. Bhardwaj. 1993. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte conditioned medium. J. Exp. Med. 178:1067-1078.
41. Dhawan, S., L.A. Toro, B.E. Jones, and M.S. Meltzer. 1992. Interactions between HIV infected monocytes and the extracellular matrix: HIV-infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices. J. Leukocyte Biol. 52:244-248.
42. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, et al. 1996. Fas ligand in human serum. Nat. Med. 2:312-322.
43. Sarsfield, P., D.B. Jones, and D.H. Wright. 1996. Accessory cells in Crohn's disease of the terminal ileum. Histopathology (Oxf.). 28:213-219.
44. Tsang, W.Y.W., J.K.C. Chan, and C.S. Ng. 1994. Kikuchi's Lymphadenitis - A morphologic analysis of 75 cases with special reference to unusual features. Am. J. Surg. Pathol. 18:219-231.
45. Armitage, R.J. 1994. Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6:407-413.
46. Sytwu, H.-K., R.S. Liblau, and H.O. McDevilt. 1996. The roles of Fas/ APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity. 5:17-30.
47. French, L.E., A. Wilson, M. Hahne, I. Viard, J. Tschopp, and H. Robson MacDonald. 1997. Fas ligand expression is restricted to nonlymphoid thymic components in situ. J. Immunol. 159:2196-2202.
48. Süss, G., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J. Exp. Med. 183:1789-1796.
49. Maraskovsky, E., K. Brasel, M. Teepe, E.R. Roux, S.D. Lyman, K. Shortman, and H.J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953-1962.
50. Oyaizu, N., N. Kayagaki, H. Yagita, S. Pahwa, and Y. Ikawa. 1997. Requirement of cell-cell contact in the induction of Jurkat T cell apoptosis: the membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells. Biochem. Biophys. Res. Commun. 238:670-675.
51. + T cells apoptosis: a possible mechanism of bystander cell death in HIV infection. J. Immunol. 158:2456-2463.
52. Holtz-Heppelmann, C.J., A. Algeciras, A.D. Badley, and C.V. Paya. 1998. Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 273:4416-4423.
53. Westendorp, M.O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.-M. Debatin, and P.M. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 375:497-500.
54. Chun, T.-W., L. Carruth, D. Finzi, X. Shen, J.A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margouck, T.C. Quinn, et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387:183-188.
55. Perelson, A.S., A.U. Neumann, M. Markowitz, J.M. Leonard, and D.D. Ho. 1996. H1V-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 271:1582-1586.
56. Muro-Cacho, C.A., G. Pantaleo, and A.S. Fauci. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154:5555-5566.